Iota Biosciences

About:

Iota Biosciences is a Biotech Company.

Website: https://iota.bio/

Top Investors: Berkeley SkyDeck Fund, The House Fund, Bold Capital Partners, Shanda Group, Astellas Pharma

Description:

Founded in 2017 to build on the award-winning ultrasound technology invented at the University of California, Berkeley, iota Biosciences is working to improve human life by pioneering cutting-edge bioelectronics. Since launch, driven by passion and tenacity, with an unwavering commitment to quality, iota has progressed from ideation to functional technology at a significant pace. We are committed to maintaining this momentum and bringing our groundbreaking approaches to the patients who need them. Using innovative science and technology, our mission is to create and develop state-of-the-art diagnostic and therapeutic bioelectronic devices that are safe and effective. We are working to transform the way doctors manage and treat disease to make a life-changing difference for patients. Today, we are proud and privileged to be powered by Astellas, a leading global pharmaceutical company that brings experience, reach and rigor, with an ethical and transformational vision aligned with our own. Together, we are creating innovative technologies that will change patients’ lives.

Total Funding Amount:

$15M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Alameda, California, United States

Founded Date:

2017-01-01

Contact Email:

media(AT)iota.bio

Founders:

Jose Carmena, Michel Maharbiz

Number of Employees:

101-250

Last Funding Date:

2018-12-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai